腮腺肉瘤样癌:30年经验回顾
结果显示5年RFS为67.3%,5年DSS为65.7%,多因素分析仅神经周围侵犯与死亡独立相关。结论认为腮腺肉瘤样癌预后差,神经周围侵犯是最重要的预测因素。
要点
- 腮腺肉瘤样癌预后差,5年RFS 67.3%,5年DSS 65.7%。
- 神经周围侵犯是独立预后因素,与死亡独立相关。
- 复发以局部复发为主,仅40%患者可接受挽救性手术。
核心结论
- 腮腺肉瘤样癌预后差,神经周围侵犯是最重要的预测因素。
主要发现
- 平均发病年龄57.8岁,多数患者分期为T3或T4。
- 15例(42.9%)有神经周围侵犯,15例(42.9%)因临床可疑淋巴结行颈清扫,其中3例病理证实淋巴结阳性。
- 14例出现复发,最常见治疗失败模式为局部复发,仅40%患者可接受挽救性手术。
- 10例发生疾病特异性死亡,5年RFS为67.3%,5年DSS为65.7%。
- 多因素分析中,仅神经周围侵犯与死亡独立相关。
临床怎么用
- 对腮腺肉瘤样癌应重视神经周围侵犯的评估,其与死亡独立相关。
- 局部复发常见且挽救性手术机会有限,需加强局部控制与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of this study was to analyze the results of clinical treatment of sarcomatoid carcinoma in the parotid gland by reviewing 30 years of experience. METHODS: Thirty-five patients were enrolled in this study. The Kaplan-Meier methods were used to calculate the recurrence-free survival (RFS) and disease-specific survival (DSS) rates. The Cox model was used to determine the independent risk factor. RESULTS: Mean age at presentation was 57.8 years, and most of the patients were staged as tumor (T)3 or T4. Perineural invasion was noted in 15 (42.9%) patients. Fifteen (42.9%) patients received neck dissection due to clinically suspicious nodes. Of those, three patients had pathologically positive nodes. Recurrence was noted in 14 patients; the most common pattern of treatment failure was local recurrence, and only 40% of the patients could receive salvaged surgical treatment. Disease-specific death was noted in 10 patients. The 5-year RFS and DSS rates were 67.3% and 65.7%, respectively. In a multivariate analysis, only the factor of perineural invasion was independently correlated with death. CONCLUSION: Parotid sarcomatoid carcinoma carries a poor prognosis, and perineural invasion was the most important predictive factor. LEVEL OF EVIDENCE: 2b Laryngoscope, 129:1137-1140, 2019.
引用
- Niu X. Sarcomatoid Carcinoma in the Parotid Gland: A Review of 30 Years of Experience. Laryngoscope. 2018. PMID: 30152029. doi:10.1002/lary.27474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。